Home › Funds › Two Sigma Investments › RLYB
Two Sigma Investments position in RLYB
RALLYBIO CORP · Health Care
Latest position (Q2 2026)16.62K sh
Reported value held$265.90K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 53.25K | $71.36K | New |
| Q3 2024 | 86.32K | $101.00K | Add |
| Q4 2024 | 76.81K | $73.74K | Reduce |
| Q1 2025 | 66.71K | $43.66K | Reduce |
| Q2 2025 | 63.79K | $21.56K | Reduce |
| Q3 2025 | 21.45K | $10.71K | Reduce |
| Q4 2025 | 37.00K | $25.39K | Add |
| Q2 2026 | 16.62K | $265.90K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLYB
- Citadel Advisors 7.71M sh · $12.73M · Q2 2026
- Fidelity Management & Research (FMR) 794.72K sh · $12.72M · Q2 2026
- Viking Global Investors 524.35K sh · $8.39M · Q2 2026
- Renaissance Technologies 199.91K sh · $3.20M · Q2 2026
- Vanguard Group 1.02M sh · $697.15K · Q4 2025
- Geode Capital Management 32.05K sh · $512.87K · Q2 2026
- BlackRock Inc 30.33K sh · $485.31K · Q2 2026
- UBS Group AG 146 sh · $2.34K · Q2 2026
- Morgan Stanley 125 sh · $2.00K · Q2 2026
- Wells Fargo & Co 37 sh · $592 · Q2 2026
- JPMorgan Chase & Co 9 sh · $145 · Q2 2026